ChemT Biotechnology raises $4.0M Seed (Singapore, Jun 2026)
$4.0M
$4m Seed fundingGenerated social card
Headline
Singapore's ChemT raises $4m to bring AI to biomanufacturing - DealStreetAsia
About
ChemT Biotechnology is a Singapore-based startup that leverages artificial intelligence to enhance biomanufacturing processes in the pharmaceutical industry. The company aims to address challenges such as long development timelines and high production costs by applying AI to improve the understanding and control of cell behavior during production.
Article summary
Singapore's ChemT raises $4m to bring AI to biomanufacturing DealStreetAsia
Founder
Jie Sun
CEO & Co-founder
Investors · 5
3 hiddenRelated rounds
| Aug 13, 2026 | Graas | $17.0M | Series B | Singapore |
| Aug 11, 2026 | K2 Therapeutics | $50.0M | Seed | Singapore |
| Aug 06, 2026 | Acrab | $130.0M | Series B | Singapore |
| Jul 27, 2026 | Lingverse | $29.0M | Pre-seed | Singapore |